What is it about?

In this paper, we review the current evidence dealing with the use of Rituximab therapy in adult patients with primary glomerular diseases.

Featured Image

Read the Original

This page is a summary of: Rituximab use in adult primary glomerulopathy: where is the evidence?, Therapeutics and Clinical Risk Management, August 2016, Dove Medical Press,
DOI: 10.2147/tcrm.s114316.
You can read the full text:

Read
Open access logo

Contributors

The following have contributed to this page